Linda di Meglio
Pediatric Endocrinology · Indianapolis, INNPI 1669587176
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Eli Lilly at 40.0% of the total. Reporting peaked in 2024 at $47,272 and has fallen 61.5% since, to $18,221 in 2025. Among pediatric endocrinology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $1210.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$38K
- Sanofi-aventis U.S. LLC$29K
- Merck$10K
- Biomarin Pharmaceutical Inc.$6K
- Tandem Diabetes Care, Inc.$4K
- Novo Nordisk$3K
- plus $6K from 11 others
Across 349 payments — averaging $3998.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$486K
- Amgen$424K
- Mannkind Corporation$188K
- Eli Lilly$174K
- Janssen Research & Development, LLC$52K
- Sanofi US Services Inc.$34K
- plus $37K from 5 others
What the payments were for
- Consulting fees$57,12060%
- Speaking & faculty fees$15,07516%
- Travel & lodging$20,77622%
- Food & beverage$2,5913%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 24 | $38,209 |
| Sanofi-aventis U.S. LLC | 7 | $29,056 |
| Merck | 6 | $10,103 |
| Biomarin Pharmaceutical Inc. | 11 | $5,614 |
| Tandem Diabetes Care, Inc. | 4 | $3,571 |
| Novo Nordisk | 2 | $3,060 |
| Vertex | 4 | $2,870 |
| Zealand Pharma A/s | 3 | $1,163 |
| Mannkind Corporation | 5 | $984 |
| Medtronic(2 entities) | 5 | $322 |
| AstraZeneca | 2 | $240 |
| Ultragenyx Pharmaceutical Inc. | 1 | $110 |
| Eton Pharmaceuticals, Inc. | 1 | $108 |
| Senseonics, Incorporated | 1 | $91 |
| Pfizer | 1 | $39 |
| Kyowa Kirin, Inc. | 1 | $37 |
| Abbott | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$3,500
- VERQUVO$2,650
- HUMALOG$1,353
- AFREZZA$850
- Strensiq$240
- MINIMED 780G$178
- Alkindi$108
- KHINDIVI$108
- INCRELEX$108
How this compares
$95,601 in reported general payments places this provider in the 90th percentile of 27 pediatric endocrinology providers in Indiana.
Other pediatric endocrinology in Indianapolis
- Gordon CutlerIndianapolis$305K
- Emily SimsIndianapolis$236K
- Erik ImelIndianapolis$69K
- Jamie FeltonIndianapolis$34K
- Erica EugsterIndianapolis$21K
- John FuquaIndianapolis$20K
- Rebecca AguirreIndianapolis$13K
- Hebatullah IsmailIndianapolis$9K
- Eric ChangIndianapolis$8K
- Amy KakkanattIndianapolis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.